Author Question: Neonatal patients are more vulnerable to rapid deterioration because of ________________. a. high ... (Read 35 times)

lak

  • Hero Member
  • *****
  • Posts: 546
Neonatal patients are more vulnerable to rapid deterioration because of ________________.
 
  a. high chest wall compliance
  b. low functional residual capacity
  c. smaller surface area for gas exchange
  d. presence of fetal hemoglobin

Question 2

The minimum acceptable pH for a premature or term newborn is which of the following?
 
  a. 7.20
  b. 7.25
  c. 7.30
  d. 7.35



cupcake16

  • Sr. Member
  • ****
  • Posts: 309
Answer to Question 1

ANS: C
Neonatal and pediatric patients have smaller lungs, higher airway resistance, lower lung compli-ance, less surface area for gas exchange, and lower cardiovascular reserve than do adults; all of these factors make them more vulnerable to rapid deterioration. Although neonates have high chest wall compliance, this is not the reason for their vulnerability to rapid deterioration. It is the reason for the presence of retractions when the WOB is elevated.

Answer to Question 2

ANS: B
The minimum acceptable pH for a premature or term newborn is 7.25. Values below that level are considered inadequate, especially when the PaCO2 is greater than 50 mm Hg.



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
 

Did you know?

When Gabriel Fahrenheit invented the first mercury thermometer, he called "zero degrees" the lowest temperature he was able to attain with a mixture of ice and salt. For the upper point of his scale, he used 96°, which he measured as normal human body temperature (we know it to be 98.6° today because of more accurate thermometers).

Did you know?

If all the neurons in the human body were lined up, they would stretch more than 600 miles.

Did you know?

The U.S. Pharmacopeia Medication Errors Reporting Program states that approximately 50% of all medication errors involve insulin.

Did you know?

Approximately 15–25% of recognized pregnancies end in miscarriage. However, many miscarriages often occur before a woman even knows she is pregnant.

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

For a complete list of videos, visit our video library